Jorge Dabdoub
Internal Medicine · Norwich, CTNPI 1699729376
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 336 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by AbbVie at 27.4% of the total. Reporting peaked in 2021 at $1,423 and has fallen 65.9% since, to $485 in 2022. Among internal medicine clinicians in CT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 336 payments — averaging $12.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- GSK$472
- Boehringer Ingelheim$361
- AstraZeneca$207
- Pfizer$206
- Astellas Pharma US Inc$199
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,96395%
- Education$2085%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 116 | $1,144 |
| GSK | 48 | $472 |
| Boehringer Ingelheim | 31 | $361 |
| AstraZeneca | 11 | $207 |
| Pfizer | 11 | $206 |
| Astellas Pharma US Inc | 7 | $199 |
| Sunovion Pharmaceuticals Inc. | 23 | $188 |
| Novo Nordisk | 10 | $183 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $159 |
| Sanofi-aventis U.S. LLC | 5 | $93 |
| Amarin Pharma, Inc. | 6 | $92 |
| Ironwood Pharmaceuticals, Inc | 4 | $90 |
| Amgen | 3 | $58 |
| Eisai Inc. | 3 | $57 |
| Johnson & Johnson | 4 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Bayer | 2 | $50 |
| Endo Pharmaceuticals Inc. | 2 | $46 |
| Dermira, Inc. | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Merck | 3 | $43 |
| Abbott | 2 | $40 |
| Novartis | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Kowa Pharmaceuticals America, Inc. | 2 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Jazz Pharmaceuticals Inc. | 1 | $24 |
| BD | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Shire North American Group Inc | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
How this compares
$4,170 in reported general payments places this provider in the 90th percentile of 2,067 internal medicine providers in Connecticut.
Other internal medicine in Norwich
- Paul DeutschNorwich$25K
- Setu VoraNorwich$19K
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$1.6M
- Arthur DecillisMadison$1M
- Charles MontanoCromwell$970K
- Gary BlickNorwalk$683K
- Scott GottliebStamford$508K
- Jeffrey KatzOxford$361K
- Nicholas DainiakBridgeport$352K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.